104 related articles for article (PubMed ID: 38823387)
1. Retraction Notice to: A FBXO7/EYA2-SCF
Shen JZ; Qiu Z; Wu Q; Zhang G; Harris R; Sun D; Rantala J; Barshop WD; Zhao L; Lv D; Won KA; Wohlschlegel J; Sangfelt O; Laman H; Rich JN; Spruck C
Mol Cell; 2024 Jun; 84(12):2398. PubMed ID: 38823387
[No Abstract] [Full Text] [Related]
2. A FBXO7/EYA2-SCF
Shen JZ; Qiu Z; Wu Q; Zhang G; Harris R; Sun D; Rantala J; Barshop WD; Zhao L; Lv D; Won KA; Wohlschlegel J; Sangfelt O; Laman H; Rich JN; Spruck C
Mol Cell; 2022 Mar; 82(6):1123-1139.e8. PubMed ID: 35182481
[TBL] [Abstract][Full Text] [Related]
3. FBXO7 Confers Mesenchymal Properties and Chemoresistance in Glioblastoma by Controlling Rbfox2-Mediated Alternative Splicing.
Li S; Chen Y; Xie Y; Zhan H; Zeng Y; Zeng K; Wang L; Zhan Z; Li C; Zhao L; Chen X; Tan Y; Wang Z; Bu J; Song Y; Deng F; Zhou A
Adv Sci (Weinh); 2023 Nov; 10(33):e2303561. PubMed ID: 37822160
[TBL] [Abstract][Full Text] [Related]
4. The E3 ubiquitin ligase SCF(Fbxo7) mediates proteasomal degradation of UXT isoform 2 (UXT-V2) to inhibit the NF-κB signaling pathway.
Spagnol V; Oliveira CAB; Randle SJ; Passos PMS; Correia CRSTB; Simaroli NB; Oliveira JS; Mevissen TET; Medeiros AC; Gomes MD; Komander D; Laman H; Teixeira FR
Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129754. PubMed ID: 33010352
[TBL] [Abstract][Full Text] [Related]
5. SCF(FBXW7)-mediated degradation of p53 promotes cell recovery after UV-induced DNA damage.
Galindo-Moreno M; Giráldez S; Limón-Mortés MC; Belmonte-Fernández A; Reed SI; Sáez C; Japón MÁ; Tortolero M; Romero F
FASEB J; 2019 Oct; 33(10):11420-11430. PubMed ID: 31337255
[TBL] [Abstract][Full Text] [Related]
6. The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis.
Liang Y; Xu X; Wang T; Li Y; You W; Fu J; Liu Y; Jin S; Ji Q; Zhao W; Song Q; Li L; Hong T; Huang J; Lyu Z; Ye Q
Cell Death Dis; 2017 Jul; 8(7):e2928. PubMed ID: 28703807
[TBL] [Abstract][Full Text] [Related]
7. Innate Immune Evasion of Porcine Epidemic Diarrhea Virus through Degradation of the FBXW7 Protein via the Ubiquitin-Proteasome Pathway.
Li M; Wu Y; Chen J; Shi H; Ji Z; Zhang X; Shi D; Liu J; Tian J; Wang X; Shi Z; Zhang H; Zhang H; Guo L; Feng L
J Virol; 2022 Mar; 96(5):e0088921. PubMed ID: 34495699
[TBL] [Abstract][Full Text] [Related]
8. Gsk3β and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease.
Teixeira FR; Randle SJ; Patel SP; Mevissen TE; Zenkeviciute G; Koide T; Komander D; Laman H
Biochem J; 2016 Oct; 473(20):3563-3580. PubMed ID: 27503909
[TBL] [Abstract][Full Text] [Related]
9. Structure of a conserved dimerization domain within the F-box protein Fbxo7 and the PI31 proteasome inhibitor.
Kirk R; Laman H; Knowles PP; Murray-Rust J; Lomonosov M; Meziane el K; McDonald NQ
J Biol Chem; 2008 Aug; 283(32):22325-35. PubMed ID: 18495667
[TBL] [Abstract][Full Text] [Related]
10. Fbxo7 promotes Cdk6 activity to inhibit PFKP and glycolysis in T cells.
Harris R; Yang M; Schmidt C; Royet C; Singh S; Natarajan A; Morris M; Frezza C; Laman H
J Cell Biol; 2022 Jul; 221(7):. PubMed ID: 35670764
[TBL] [Abstract][Full Text] [Related]
11. E3 ligase adaptor FBXO7 contributes to ubiquitination and proteasomal degradation of SIRT7 and promotes cell death in response to hydrogen peroxide.
Lee SH; Lee YJ; Jung S; Chung KC
J Biol Chem; 2023 Mar; 299(3):102909. PubMed ID: 36646384
[TBL] [Abstract][Full Text] [Related]
12. KDM5c Promotes Colon Cancer Cell Proliferation Through the FBXW7-c-Jun Regulatory Axis.
Lin H; Ma N; Zhao L; Yang G; Cao B
Front Oncol; 2020; 10():535449. PubMed ID: 33042830
[TBL] [Abstract][Full Text] [Related]
13. SCF
Sugiyama S; Yumimoto K; Inoue I; Nakayama KI
Genes Cells; 2019 May; 24(5):354-365. PubMed ID: 30838725
[TBL] [Abstract][Full Text] [Related]
14. Study of an FBXO7 patient mutation reveals Fbxo7 and PI31 co-regulate proteasomes and mitochondria.
Al Rawi S; Simpson L; Agnarsdóttir G; McDonald NQ; Chernuha V; Elpeleg O; Zeviani M; Barker RA; Spiegel R; Laman H
FEBS J; 2024 Jun; 291(12):2565-2589. PubMed ID: 38466799
[TBL] [Abstract][Full Text] [Related]
15. TGFβ promotes YAP-dependent AXL induction in mesenchymal-type lung cancer cells.
Choi JY; Lee H; Kwon EJ; Kong HJ; Kwon OS; Cha HJ
Mol Oncol; 2021 Feb; 15(2):679-696. PubMed ID: 33207077
[TBL] [Abstract][Full Text] [Related]
16. The characteristics of FBXO7 and its role in human diseases.
Zhong Y; Li J; Ye M; Jin X
Gene; 2023 Jan; 851():146972. PubMed ID: 36261086
[TBL] [Abstract][Full Text] [Related]
17. Early growth response-1 is a new substrate of the GSK3β-FBXW7 axis.
Yin L; Zhang J; Sun Y
Neoplasia; 2022 Dec; 34():100839. PubMed ID: 36240645
[TBL] [Abstract][Full Text] [Related]
18. EYA2 Correlates With Clinico-Pathological Features of Breast Cancer, Promotes Tumor Proliferation, and Predicts Poor Survival.
Xu H; Jiao Y; Yi M; Zhao W; Wu K
Front Oncol; 2019; 9():26. PubMed ID: 30761270
[TBL] [Abstract][Full Text] [Related]
19. Immune Evasion Mechanism and AXL.
Son HY; Jeong HK
Front Oncol; 2021; 11():756225. PubMed ID: 34778071
[TBL] [Abstract][Full Text] [Related]
20. The F-box protein Fbxo7 interacts with human inhibitor of apoptosis protein cIAP1 and promotes cIAP1 ubiquitination.
Chang YF; Cheng CM; Chang LK; Jong YJ; Yuo CY
Biochem Biophys Res Commun; 2006 Apr; 342(4):1022-6. PubMed ID: 16510124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
